These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1292982)

  • 1. Growth hormone and insulin interactions.
    Caprio S; Boulware D; Tamborlane V
    Horm Res; 1992; 38 Suppl 2():47-9. PubMed ID: 1292982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance: an early metabolic defect of Turner's syndrome.
    Caprio S; Boulware S; Diamond M; Sherwin RS; Carpenter TO; Rubin K; Amiel S; Press M; Tamborlane WV
    J Clin Endocrinol Metab; 1991 Apr; 72(4):832-6. PubMed ID: 2005209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
    Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
    Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement.
    Gravholt CH; Naeraa RW; Nyholm B; Gerdes LU; Christiansen E; Schmitz O; Christiansen JS
    Diabetes Care; 1998 Jul; 21(7):1062-70. PubMed ID: 9653596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone treatment on hyperinsulinemia associated with Turner syndrome.
    Caprio S; Boulware SD; Press M; Sherwin RS; Rubin K; Carpenter TO; Plewe G; Tamborlane WV
    J Pediatr; 1992 Feb; 120(2 Pt 1):238-43. PubMed ID: 1735819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone.
    Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H
    J Clin Endocrinol Metab; 1996 Feb; 81(2):536-41. PubMed ID: 8636264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome.
    Gravholt CH; Hjerrild BE; Naeraa RW; Engbaek F; Mosekilde L; Christiansen JS
    Clin Endocrinol (Oxf); 2005 May; 62(5):616-22. PubMed ID: 15853835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent effect of growth hormone therapy on glucose metabolism in subjects with Turner syndrome. The German Lilly Ullrich-Turner Syndrome Study Group.
    Weise M; James D; Hartmann KH; Reinhardt D; Leitner C; Böhles HJ; Attanasio A
    Horm Res; 1993; 39 Suppl 2():25-9. PubMed ID: 8359785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
    Saggese G; Federico G; Cinquanta L
    Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and craniofacial changes: preliminary data from studies in Turner's syndrome.
    Simmons KE
    Pediatrics; 1999 Oct; 104(4 Pt 2):1021-4. PubMed ID: 10506256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone secretion in pubertal age patients with Turner's syndrome.
    Lanes R; Brito S; Suniaga M; Moncada G; Borges M
    J Clin Endocrinol Metab; 1990 Sep; 71(3):770-2. PubMed ID: 2394779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone therapy for patients with Turner's syndrome.
    Singer-Granick C; Lee PA; Foley TP; Becker DJ
    Horm Res; 1986; 24(4):246-50. PubMed ID: 3781482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of apparent growth hormone-dependent growth failure during puberty: a case report.
    Weissberger AJ; Ho KY; Lazarus L
    Horm Res; 1989; 32(4):148-50. PubMed ID: 2696721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing insulin resistance: application of a fasting glucose to insulin ratio in growth hormone-treated children.
    Burgert TS; Vuguin PM; DiMartino-Nardi J; Attie KM; Saenger P
    Horm Res; 2002; 57(1-2):37-42. PubMed ID: 12006718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow baseline growth and a good response to growth hormone (GH) therapy are related to elevated spontaneous GH pulse frequency in girls with Turner's syndrome.
    Kamp GA; Kuilboer MM; Wynne HJ; Rongen-Westerlaken C; Johnson ML; Veldhuis JD; Wit JM
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1604-9. PubMed ID: 8501169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
    Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth response relationship between growth hormone dose and short term growth in patients with Turner's syndrome.
    Ross JL; Long LM; Skerda M; Cassorla F; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1028-30. PubMed ID: 3745402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate and lipid metabolism in Turner syndrome: effect of therapy with growth hormone, oxandrolone, and a combination of both.
    Wilson DM; Frane JW; Sherman B; Johanson AJ; Hintz RL; Rosenfeld RG
    J Pediatr; 1988 Feb; 112(2):210-7. PubMed ID: 3276862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.